BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19657116)

  • 21. [Influence on matrix metalloproteinases 3, 9, and 13 levels after blocking stromal cell derived factor 1/chemokine receptor 4 signaling pathway with AMD3100].
    Li Y; Wang G; Cao B; Gao G; Ma K; Chen W; Xu P; Yang G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Jun; 26(6):652-6. PubMed ID: 22792756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
    Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N
    Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromal cell-derived factor-1 induces matrix metalloprotease-13 expression in human chondrocytes.
    Chiu YC; Yang RS; Hsieh KH; Fong YC; Way TD; Lee TS; Wu HC; Fu WM; Tang CH
    Mol Pharmacol; 2007 Sep; 72(3):695-703. PubMed ID: 17550983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of SDF-1alpha and CXCR4 plays an important role in pulmonary cellular infiltration in differentiation syndrome.
    Zhou J; Hu L; Cui Z; Jiang X; Wang G; Krissansen GW; Sun X
    Int J Hematol; 2010 Mar; 91(2):293-302. PubMed ID: 20084476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.
    Hatse S; Princen K; Bridger G; De Clercq E; Schols D
    FEBS Lett; 2002 Sep; 527(1-3):255-62. PubMed ID: 12220670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulated stromal cell-derived factor 1 (SDF-1) expression and its interaction with CXCR4 contribute to the pathogenesis of severe pterygia.
    Kim KW; Park SH; Lee SH; Kim JC
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7198-206. PubMed ID: 24114538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments.
    Stamatopoulos B; Meuleman N; De Bruyn C; Pieters K; Mineur P; Le Roy C; Saint-Georges S; Varin-Blank N; Cymbalista F; Bron D; Lagneaux L
    Haematologica; 2012 Apr; 97(4):608-15. PubMed ID: 22058221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and function of CXCR4 in human salivary gland cancers.
    Uchida D; Kuribayashi N; Kinouchi M; Ohe G; Tamatani T; Nagai H; Miyamoto Y
    Clin Exp Metastasis; 2013 Feb; 30(2):133-42. PubMed ID: 22847686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway.
    Zheng H; Fu G; Dai T; Huang H
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):274-80. PubMed ID: 17878755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
    Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
    Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SDF-1/CXCR4 chemokine axis in uveal melanoma cell proliferation and migration.
    Bi J; Li P; Li C; He J; Wang Y; Zhang H; Fan X; Jia R; Ge S
    Tumour Biol; 2016 Mar; 37(3):4175-82. PubMed ID: 26490988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
    Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
    Song JS; Kang CM; Kang HH; Yoon HK; Kim YK; Kim KH; Moon HS; Park SH
    Exp Mol Med; 2010 Jun; 42(6):465-72. PubMed ID: 20498529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis.
    Gomes AL; Carvalho T; Serpa J; Torre C; Dias S
    Blood; 2010 May; 115(19):3886-94. PubMed ID: 20009035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
    Juarez JG; Harun N; Thien M; Welschinger R; Baraz R; Pena AD; Pitson SM; Rettig M; DiPersio JF; Bradstock KF; Bendall LJ
    Blood; 2012 Jan; 119(3):707-16. PubMed ID: 22049516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SDF-1 and CXCR4 play an important role in adult SVZ lineage cell proliferation and differentiation.
    Zhu C; Yao WL; Tan W; Zhang CH
    Brain Res; 2017 Feb; 1657():223-231. PubMed ID: 27288704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis.
    Shu HK; Yoon Y; Hong S; Xu K; Gao H; Hao C; Torres-Gonzalez E; Nayra C; Rojas M; Shim H
    PLoS One; 2013; 8(11):e79768. PubMed ID: 24244561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Lentiviral CXCR4 overexpression and knockdown model in colorectal cancer cell lines reveals plerixafor-dependent suppression of SDF-1α-induced migration and invasion.
    Heckmann D; Laufs S; Maier P; Zucknick M; Giordano FA; Veldwijk MR; Eckstein V; Wenz F; Zeller WJ; Fruehauf S; Allgayer H
    Onkologie; 2011; 34(10):502-8. PubMed ID: 21985848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4 but not CXCR7 is mainly implicated in ocular leukocyte trafficking during ovalbumin-induced acute uveitis.
    Zhang Z; Zhong W; Hall MJ; Kurre P; Spencer D; Skinner A; O'Neill S; Xia Z; Rosenbaum JT
    Exp Eye Res; 2009 Oct; 89(4):522-31. PubMed ID: 19524567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
    Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
    Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.